Adverum Biotechnologies

Acquired

Redefining sight for life.

Adverum Biotechnologies was founded in 2012, is headquartered in Redwood City, United States, lists 51–200 employees, and has $182.5M in recorded funding across 2 rounds.

Employees
51–200
Founded
2012
Total Funding
$182.5M
Last Round
$127.5M Private EquityFeb 2024
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 4 investors for this company. The full record is or through the API.

About

Adverum Biotechnologies is a clinical-stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases, with the goal of developing functional cures that restore vision and prevent blindness. Leveraging its proprietary intravitreal (IVT) platform, Adverum is developing ixoberogene soroparvovec (Ixo-vec), a one-time, single-administration gene therapy for wet age-related macular degeneration, delivered in physicians' offices to eliminate the need for frequent ocular injections. Adverum is now a wholly-owned subsidiary of Eli Lilly and Company, following completion of Lilly's acquisition announced in October 2025.

Summary

Adverum Biotechnologies is a Biotech company based in Redwood City, United States, founded in 2012. It lists 51–200 employees. It has raised $182.5M in total across 2 rounds, most recently a $127.5M Private Equity round in Feb 2024. Investors include TCGX, 5AM Ventures and Commodore Capital.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Private EquityPrivate EquityFeb 2024
$127.5M

Sign up to see all 2 events

Funding: Series B through Private Equity. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Adverum Biotechnologies on Indexed.vc
<a href="https://indexed.vc/companies/adverum-biotechnologies"><img src="https://indexed.vc/api/badge/company/adverum-biotechnologies" alt="Adverum Biotechnologies on Indexed.vc" width="260" height="76" /></a>